Product Images Clopidogrel Bisulfate

This is a description of clopidogrel tablets containing 300 mg of clopidogrel base. The tablets are film-coated and come in a package of 30 tablets. The storage instructions are to keep the tablets at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The tablets are distributed by Dr. Reddy's Laboratories Inc. and the expiration date is R02/2025. It is recommended to follow the Medication Guide provided with each patient's prescription.*

This text provides information about the effect of co-administering different proton pump inhibitors (PPIs) on the area under the curve (AUC) of the active metabolite. The AUC is presented as mean values and 90% confidence intervals for Dexlansoprazole (60 mg), Lansoprazole (30 mg), Pantoprazole (80 mg), and Omeprazole (80 mg). The values for each PPI are listed as follows: Dexlansoprazole - T, Lansoprazole - T, Pantoprazole - T, Omeprazole - T. The data seems to be related to a study or pharmacokinetic analysis of these PPIs and their impact on active metabolite AUC.*

This text provides information on the event rate of Clopidogrel in combination with aspirin over a 12-month follow-up period. Other standard therapies were also utilized as needed.*

This text provides information on the comparison of mortality rates between Placebo and Clopidogrel treatments, with 1845 deaths (8.1%) in the Placebo group and 1726 deaths (7.5%) in the Clopidogrel group. The analysis shows a 7% proportional risk reduction with a p-value of 0.03. The data is presented in the context of days since randomization (up to 28 days).*

This text appears to be a comparison between two groups, one taking a placebo and the other taking Clopidogrel. The study evaluated the occurrence of death, reinfarction, or stroke before discharge from the hospital. The placebo group had 2310 events (10.1%), while the Clopidogrel group had 2121 events (9%), indicating a 9% proportional risk reduction with Clopidogrel (p=0.002). The evaluation was conducted over a period of up to 28 days since randomization.*